Clinical Trials Browser

Interventional × abiraterone × Tumor-Agnostic × Clear all

NCT03480646 2025-10-29

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Completed

175 enrolled 23 charts

Neoplasms

NCT03295565 2022-04-15

OSTRICh

Phase 2/3 Completed

Neoplasm Metastasis

NCT02380313 2016-10-06

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

Phase 1 Withdrawn

Neoplasms